Article info
PDFCommentary
A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis
- Correspondence to Professor Eithne Costello, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, 2nd Floor Sherrington Building, Ashton Street, Liverpool L69 3GE, UK; ecostell{at}liverpool.ac.uk
Citation
A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis
Publication history
- Received February 8, 2017
- Revised April 10, 2017
- Accepted April 11, 2017
- First published May 24, 2017.
Online issue publication
March 28, 2018
Article Versions
- Previous version (28 March 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.